LOADING
Synergy is a Russian contract research organization.
Since the very first clinical trials in the late 1990s and the simultaneous implementation of the ICH GCP (International Conference on Harmonization – Good Clinical Practice) standards, we have witnessed the unleashing of Russia’s enormous potential in clinical trials, which continues to unfold to the fullest extent of its capabilities.
We know our native Russian market of clinical trials thoroughly, at our fingertips, and we share our knowledge in the quarterly reports of Synergy Orange Paper.
The quality of data generated in clinical trials in Russia usually is very high, largely due to the qualifications and professionalism of the investigators.
The recruitment rates for clinical trials in Russia are among the highest in the world, and the trusting format of the doctor-patient relationship, which is typical for the national mentality, contributes to achieving high patient retention rates throughout the study. Besides, Russian patients, as a rule, strictly comply with all study procedures and requirements from the start to the end, which does not apply to all countries.
In some cases, especially for innovative therapies, participation in clinical trials is the only way for patients to access modern treatments for their diseases. Also, clinical trials offer patients quick access to costly diagnostic and therapeutic procedures.
The main standards for conducting clinical trials of medicines and medical devices in Russia include federal laws, documents of the Eurasian Economic Union (EAEU) and departmental regulations harmonized with the requirements of international standards ICH GCP and the Declaration of Helsinki.
We are able to work with clients all over the world, both from Western countries and from the Asia-Pacific region.
The quality of clinical trials conducted in Russia is confirmed not only by the level of results obtained, but also by numerous inspections by foreign regulatory authorities (FDA, EMA).
We are able to work both as the only contract research organization selected by the Sponsor to conduct a clinical trial, and as part of an international multicenter project team, interacting with other contract research organizations and service providers.
We also offer access to an extensive database of treatment-naïve patients and a well-organized infrastructure for conducting clinical trials of medicines and medical devices in the Russian Federation, along with high quality of the obtained statistical data and the possibility of preparing these data in native formats for foreign regulators.
You are very responsive and work very proactively and I’d like to recognize your dedication and commitment with the study by sending you this email. THANK YOU and WELL DONE!!!! It is a real pleasure to work with you.